Enhancing the biocatalytic manufacture of the key intermediate of atorvastatin by focused directed evolution of halohydrin dehalogenase
Crossref DOI link: https://doi.org/10.1038/srep42064
Published Online: 2017-02-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luo, Yu
Chen, Yangzi
Ma, Hongmin
Tian, ZhenHua
Zhang, Yeqi
Zhang, Jian
Text and Data Mining valid from 2017-02-06
Version of Record valid from 2017-02-06
Article History
Received: 4 August 2016
Accepted: 5 January 2017
First Online: 6 February 2017
Competing interests
: The authors declare no competing financial interests.